Eltrombopag Tablet (Orken) Manufacturers India & Exporters
Taj Pharmaceuticals – Trusted Eltrombopag 50mg Tablet (Orken) Manufacturer in India
Taj Pharmaceuticals, based in Vapi, Gujarat, is a leading manufacturer, exporter, and supplier of Eltrombopag 50mg Tablets (Orken) in India. Our reputation is built on consistent quality, international regulatory compliance, and high-end pharmaceutical manufacturing capabilities. We serve a broad clientele across India, Africa, LATAM, and the Middle East, making us the preferred global supplier of Eltrombopag Tablets.
Eltrombopag, a thrombopoietin receptor agonist, is primarily used to treat low platelet counts in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP), chronic hepatitis C virus (HCV) infection, and severe aplastic anemia (SAA).
Eltrombopag 50mg Tablets – Overview
Eltrombopag is a breakthrough therapy for individuals suffering from low platelet disorders, where traditional treatments may not suffice. It stimulates platelet production by binding to the thrombopoietin receptor, leading to increased platelet counts and reduced risk of bleeding.
- Generic Name: Eltrombopag Olamine
- Brand Name: Orken (as marketed by Taj Pharma)
- Strength: 50mg
- Form: Film-coated oral tablet
- Therapeutic Class: Hematopoietic agents
- Route of Administration: Oral
- Packing: Blister pack of 7 tablets
Mechanism of Action of Eltrombopag
Eltrombopag mimics the activity of thrombopoietin (TPO), the body’s natural growth factor responsible for platelet production. It activates the TPO receptor (c-Mpl) on bone marrow progenitor cells, leading to increased production of megakaryocytes and subsequently, platelets. This mechanism is particularly beneficial in conditions like:
- Chronic ITP – where the immune system destroys platelets.
- HCV-related thrombocytopenia – where antiviral treatment is hindered due to low platelet levels.
- Severe aplastic anemia – where bone marrow fails to produce sufficient blood cells.
Therapeutic Indications
Taj Pharma’s Eltrombopag 50mg Tablet is indicated for:
- Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) in adults and children (≥1 year) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
- Thrombocytopenia in patients with chronic HCV infection, to enable initiation and maintenance of interferon-based therapy.
- Severe Aplastic Anemia (SAA) in adult patients who have had an insufficient response to immunosuppressive therapy.
Dosage and Administration Guidelines
Eltrombopag should be taken on an empty stomach, either 1 hour before or 2 hours after food, especially food high in calcium. The dose should always be personalized based on platelet counts and clinical response.
- ITP Initial Dose: 50mg once daily.
- HCV-associated thrombocytopenia: Start with 25mg/day; adjust per platelet response.
- Severe Aplastic Anemia: 50mg/day, titrated based on response and tolerability.
Important Note: Always follow your physician’s exact dosing instructions.
Precautions and Warnings
- Monitor liver function tests (LFTs) before and during treatment.
- Use cautiously in patients with hepatic impairment.
- Avoid concomitant use with aluminum, calcium, iron, magnesium, selenium, or zinc supplements within 4 hours of taking the tablet.
- Risk of thromboembolic complications – monitor closely in patients with risk factors.
Side Effects of Eltrombopag Tablets
Eltrombopag is generally well tolerated. However, possible side effects include:
- Headache
- Nausea
- Fatigue
- Increased liver enzymes (ALT/AST)
- Cataracts (long-term use)
- Blood clots (in rare cases)
Patients should undergo regular eye examinations and blood monitoring to detect complications early.
Why Choose Taj Pharmaceuticals for Eltrombopag Tablets
High-Quality Manufacturing Standards
Taj Pharmaceuticals operates WHO-GMP and ISO-certified facilities, ensuring that every batch of Eltrombopag 50mg Tablet adheres to stringent quality control and international regulatory standards.
PAN India & Global Supply Chain
We ensure timely and efficient distribution of Eltrombopag across India and globally—serving Latin America, Africa, the Middle East, and CIS countries with a robust logistics network.
Regulatory Support
Taj Pharma offers complete regulatory documentation support including:
- COAs (Certificate of Analysis)
- Stability Data
- CTD Dossiers
- Bioequivalence Studies (on request)
PCD Pharma Franchise Opportunities
We invite ethical pharma professionals to partner with us under PCD Franchise for Eltrombopag Tablets, backed by:
- Monopoly rights
- Attractive promotional inputs
- High profit margins
- Fast-moving, high-demand product line
Eltrombopag Tablet Exporter and Supplier – Global Reach
Taj Pharmaceuticals has earned the status of a premium exporter of Eltrombopag 50mg Tablets. Our products are in high demand in:
- Nigeria, Kenya, Ghana, South Africa
- UAE, Iraq, Saudi Arabia, Jordan
- Brazil, Colombia, Peru, Mexico
We guarantee pharmacovigilance compliance, customized labeling, and prompt export documentation handling.
Eltrombopag 50mg Tablet – Technical Details
| Parameter | Specification |
|---|---|
| Product Name | Eltrombopag 50mg Tablet |
| Brand Name | Orken |
| Manufactured By | Taj Pharmaceuticals Ltd., Vapi, Gujarat, India |
| Dosage Form | Oral Tablet |
| Therapeutic Use | Hematology – Thrombocytopenia |
| Packing Type | Blister |
| Route of Administration | Oral |
| Storage Conditions | Store below 30°C, protect from moisture |
| Regulatory Support | Dossier Available |
Eltrombopag Tablets – FAQ
Q1: What is the use of Eltrombopag 50mg Tablet?
Eltrombopag is used to treat low platelet counts due to chronic ITP, HCV, and severe aplastic anemia.
Q2: Is Eltrombopag safe in liver disease?
It must be used with caution and close monitoring in hepatic impairment. Liver enzymes should be tested regularly.
Q3: How long does Eltrombopag take to show effects?
Most patients begin to see a rise in platelet count within 2–3 weeks of starting therapy.
Q4: Can Eltrombopag be taken with calcium-rich food?
No. Calcium interferes with absorption. Take Eltrombopag 1 hour before or 2 hours after meals that contain calcium.
Connect with Taj Pharma – Your Reliable Partner in Hematology Solutions
If you’re a distributor, hospital, procurement agency, or PCD franchise partner, Taj Pharmaceuticals offers you high-quality Eltrombopag Tablets at the most competitive prices. We deliver efficacy, consistency, and service excellence in every supply.
📧 Email: info@tajpharma.com
🌍 Website: www.tajpharma.com
📞 Call/WhatsApp: +91 84484 44095
📍 Address: Vapi, Gujarat, India
Relevant Search Terms We Dominate
- Eltrombopag 50mg Tablet Manufacturer Vapi Gujarat
- Eltrombopag Tablets Suppliers in India
- Eltrombopag Tablet Best Price Mumbai Maharashtra
- PCD Franchise for Eltrombopag Tablet
- Leading Eltrombopag Exporters from India
